Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-012049
Date:2021-02-16
Issuer: DECIPHERA PHARMACEUTICALS, INC. (DCPH)
Original Submission Date:

Reporting Person:

HOERTER STEVEN L.
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET WALTHAM, MA 02451

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 47.79 2021-02-16 deemed execution date A 210,000 (d) 2031-02-15 common stock 210,000 $47.79 210,000 direct
Footnotes
IDfootnote
f1 this stock option was issued pursuant to the issuer's 2017 stock option and incentive plan. the option shall vest in equal monthly installments over four years, beginning on march 16, 2021.
WhaleWisdom Logo

Elevate your investments